Amid pollution woes, Asthma drug demand drives pharma retail market growth in November

India's pharmaceutical retail market rebounded in November with double-digit growth, fueled by increased demand for dermatological, cardiac, and respiratory medications. Foracort led sales, followed by Augmentin and Glycomet GP. Sun Pharma maintained market leadership. Analysts predict continued growth, boosted by new product launches, including anticipated generic GLP-1 drugs in 2025.